Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A clinicogenetic model to predict lymph node invasion by use of genome-based biomarkers from exome arrays in prostate cancer patients.

Korean journal of urology - 1 Feb 2015

Oh Jong Jin, Park Seunghyun, Lee Sang Eun, Hong Sung Kyu, Lee Sangchul, Lee Hak Min, Lee Jeung Keun, Ho Jin-Nyoung, Yoon Sungroh, Byun Seok-Soo

Abstract excerpt

PURPOSE: Genetic variations among prostate cancer (PCa) patients who underwent radical prostatectomy (RP) and pelvic lymph node dissection were evaluated to predict lymph node invasion (LNI). Exome arrays were used to develop a clinicogenetic model that combined clinical data related to PCa and individual genetic variations. MATERIALS AND METHODS: We genotyped 242,186 single-nucleotide polymorphisms (SNPs) by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Exome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymph Node Excision

Share to Lymph Nodes

Share to Lymphatic Metastasis

Share to Neoplasm Invasiveness

Share to Prostatectomy

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 25685297
DOI: 10.4111/kju.2015.56.2.109
PMCID: PMC4325114

Genes

BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A clinicogenetic model to predict lymph node invasion by use of genome-based biomarkers from exome arrays in prostate cancer patients.PMID 25685297Read ↗

Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.Semantic proximity Read ↗

Genome-wide detection of allelic genetic variation to predict advanced-stage prostate cancer after radical prostatectomy using an exome SNP chip.Semantic proximity Read ↗

The use of exome genotyping to predict pathological Gleason score upgrade after radical prostatectomy in low-risk prostate cancer patients.Semantic proximity Read ↗

Exome-based genome-wide association study and risk assessment using genetic risk score to prostate cancer in the Korean population.Semantic proximity Read ↗

Genetic predisposition to early recurrence in clinically localized prostate cancer.Semantic proximity Read ↗

Prediction of clinically significant prostate cancer using polygenic risk models in Asians.Semantic proximity Read ↗

The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approachesSemantic proximity Read ↗

A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation.Semantic proximity Read ↗

Genetic variants in epithelial-mesenchymal transition genes as predictors of clinical outcomes in localized prostate cancer.Semantic proximity Read ↗

Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?Semantic proximity Read ↗

Single Nucleotide Polymorphisms Associated with Prostate Cancer Progression: A Systematic Review.Semantic proximity Read ↗

Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.